Boehringer’s Commitment to Metabolic Diseases
Downloads
Cardiovascular, renal, and metabolic conditions infographic
Learn more about the Cardiovascular, renal, and metabolic conditions infographic.
Latest News on Metabolic Diseases
November 04, 2022
Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
May 26, 2020